A β-cyclodextrin glucosyltransferase, its preparation method and its application

By optimizing the amino acid sequence and constructing a β-cyclodextrin glucosyltransferase from a heterologous expression strain to catalyze steviol glycosides and soluble starch, the problems of long production cycle and monotonous taste of glucosyl steviol glycosides in existing technologies have been solved, achieving efficient and low-cost industrial production.

CN115896056BActive Publication Date: 2026-11-17HANGZHOU WAHAHA TECH +1
View PDF 3 Cites 0 Cited by

Patent Information

Application Number
CN202210937689.5
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Filing Date
2022-08-05
Publication Date
2026-11-17
Estimated Expiration
2042-08-05

AI Technical Summary

Technical Problem

In existing technologies, the production of glucosylsteviosides results in a fixed variety of products, a monotonous taste, and a long production cycle.

Method used

A β-cyclodextrin glucosyltransferase is provided, which catalyzes the preparation of glucosylstevioside from steviol glycosides and soluble starch by optimizing the amino acid sequence SEQ ID NO:2 and constructing a heterologous expression strain, using specific reaction conditions of pH, temperature and time.

Benefits of technology

It achieves short production cycle, low cost, and high conversion rate, and produces glucosylstevioside with high sweetness and fast sweetening speed, making it valuable for industrial production.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure BDA0003784124270000061
    Figure BDA0003784124270000061
  • Figure BDA0003784124270000071
    Figure BDA0003784124270000071
  • Figure HDA0003784124280000011
    Figure HDA0003784124280000011
Patent Text Reader

Abstract

This invention relates to the field of biotechnology, and discloses a β-cyclodextrin glucosyltransferase, its preparation method, and its application. The β-cyclodextrin glucosyltransferase is selected from one or more of the following: a polypeptide with the amino acid sequence SEQ ID NO:2; a polypeptide and its derivatives with β-cyclodextrin glucosyltransferase activity formed by substituting, deleting, or adding one or more amino acid residues of the amino acid sequence SEQ ID NO:2; and a protein fragment containing SEQ ID NO:2 and having β-cyclodextrin glucosyltransferase activity. This enzyme has high steviol glycoside conversion efficiency, achieving a Stev conversion rate of 86.1% and a RebA conversion rate of 90.8% for steviol glycosides. It has a short production cycle, low cost, and high conversion rate. The glucosyl steviol glycosides produced have the technical effects of high sweetness and rapid sweetening.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] This invention relates to the field of biotechnology, and in particular to a β-cyclodextrin glucosyltransferase, its preparation method, and its applications. Background Technology

[0002] High-sugar diets bring numerous diseases and health risks. As awareness of the dangers of excessive sugar intake and health consciousness continue to rise, low-sugar diets have become a global trend. In 2017, the State Council issued the "National Nutrition Plan (2017-2030)," which clearly proposed the "Three Reductions and Three Healths" (reducing salt, oil, and sugar intake; promoting oral health, healthy weight, and healthy bones) action plan. The implementation of this plan has greatly promoted the research, development, production, and consumption of low-sugar and sugar-free foods, and the market demand for steviol glycosides (natural sweeteners) and glucosyl steviol glycosides (flavorings) is also increasing. Steviol glycosides have a strong bitter and astringent taste, and their perceived sweetness and bitterness are related to the total number of glucose units attached to them. Steviol glycosides with fewer β-glucose residues have a more pronounced bitterness compared to glucosyl steviol glycosides with more β-glucose residues. Currently, the market mainly uses cyclodextrin glucosyltransferase (CGTase) to catalyze the conversion of starch and steviol glycosides into glucosyl steviol glycosides.

[0003] For example, CN111662941A discloses a method for preparing glucosylstevioside, characterized by: (1) Stevia extract and cyclodextrin are mixed at a mass ratio of 1:1-2 to prepare a 10%-60% mixed solution, and the mixture is stirred and preheated at 40-80℃ for 1-3h to generate a suspension; (2) Cyclodextrin glycosyltransferase is added and controlled to be 2-10% of the mass of cyclodextrin, and the mixture is stirred at 40-80℃ and 100-300rpm / min for 1-96h, and the temperature is raised to above 105℃ for 30-60min; (3) The reaction solution is decolorized with a decolorizing resin, and the decolorized solution is desalted with anion and cation exchange resins. After desalting, the solution is desalted with macroporous adsorption resin to remove non-diterpenoid compounds, the column is washed with water, and the solution is desorbed with 20-70% ethanol and the ethanol eluent is collected; (4) The ethanol eluent is evaporated and concentrated to control the stevioside mass concentration to be above 60%, and then spray-dried.

[0004] For example, CN108103127A discloses a method for the rapid industrial production of a mixture of glucosyl steviol glycosides. The method includes the following steps: Step 1, enzymatic reaction: Dissolve oxidized starch and steviol glycosides, add CGTase to carry out the enzymatic reaction at a temperature of 40℃~55℃ for 7~12h, and terminate the reaction by inactivating the enzyme; Step 2, decolorization and deodorization; Step 3, filtration, concentration, and drying to obtain the product. This invention uses oxidized starch as the glycoside donor, reducing process steps, improving the glycosylation effect, and simplifying the process. It also reduces the requirements for equipment and energy consumption in industrial production, shortens working hours, reduces costs, and increases unit production capacity.

[0005] The applicant found in actual production that existing technologies mostly use CGTase produced by Novozymes, which results in fixed product types and a single taste. At the same time, the production cycle of glucosylstevioside in existing technologies is long. Summary of the Invention

[0006] To overcome the problems of fixed product types, monotonous product taste, and long production cycle in the production of glucosylstevioside in the prior art, this application provides a β-cyclodextrin glucosyltransferase, its preparation method, and its application. The β-cyclodextrin glucosyltransferase in this application has the amino acid sequence SEQ ID NO:2. This application provides a method for preparing β-cyclodextrin glucosyltransferase, which involves codon optimization of the amino acid sequence SEQ ID NO:2, ligating the optimized nucleotide sequence into a vector, introducing it into a host, obtaining an engineered strain capable of expressing β-cyclodextrin glucosyltransferase, and then culturing the engineered strain to prepare β-cyclodextrin glucosyltransferase. This application also provides the application of this enzyme in the preparation of glucosylstevioside from steviol glycosides and soluble starch. This application has the technical advantages of short production cycle, low cost, high conversion rate, high sweetness of the produced glucosylstevioside, and rapid sweetening speed.

[0007] The specific technical solution of this invention is as follows:

[0008] A β-cyclodextrin glucosyltransferase, selected from one or more of the following: a polypeptide with the amino acid sequence SEQ ID NO:2; a polypeptide and its derivatives formed by substituting, deleting or adding one or more amino acid residues of the amino acid sequence SEQ ID NO:2 to have β-cyclodextrin glucosyltransferase activity; and a protein fragment containing SEQ ID NO:2 in its amino acid sequence and having β-cyclodextrin glucosyltransferase activity.

[0009] This application provides a novel β-cyclodextrin glucosyltransferase with the amino acid sequence SEQ ID NO:2. This amino acid sequence is derived from the β-cyclodextrin glucosyltransferase of Bacillus osimai with accession number CGMCC No.23164. This β-cyclodextrin glucosyltransferase can catalyze the conversion of steviol glycosides and soluble starch into glucosylsteviosides. It has a high steviol glycoside conversion efficiency, with a Stev conversion rate of up to 86.1% and a RebA conversion rate of up to 90.8% for steviol glycosides.

[0010] A method for preparing the β-cyclodextrin glucosyltransferase as described in claim 1, the preparation method is as follows:

[0011] (1) Preparation of polynucleotides: Polynucleotides were prepared according to the amino acid sequence SEQ ID NO:2;

[0012] (2) Preparation of heterologous expression plasmid: The polynucleotide ligation vector in step (1) is used to construct a heterologous expression plasmid;

[0013] (3) Preparation of heterologous expression strains: Transform the heterologous expression plasmid from step (2) into the host to obtain heterologous expression strains;

[0014] (4) Preparation of β-cyclodextrin glucosyltransferase: The heterologous expression strain in step (3) is fermented. After fermentation, the culture is collected and centrifuged. β-cyclodextrin glucosyltransferase is isolated from the fermentation supernatant or bacterial cells obtained by centrifugation.

[0015] This application provides a method for preparing β-cyclodextrin glucosyltransferase. The method first prepares a polynucleotide based on the amino acid sequence SEQ ID NO:2, then proceeds to the following steps: heterologous expression plasmid construction, heterologous expression strain construction, heterologous expression strain fermentation, and protein purification to obtain β-cyclodextrin glucosyltransferase. The β-cyclodextrin glucosyltransferase expressed by the constructed heterologous expression strain has the characteristics of short conversion cycle, low cost, and high conversion rate. Furthermore, the glucosylstevioside produced using this enzyme has high sweetness and rapid sweetening speed, possessing significant industrial production value. This invention provides a new option for the industrial production of β-cyclodextrin glucosyltransferase.

[0016] Preferably, the polynucleotide in step (1) is selected from either SEQ ID NO:1 or SEQ ID NO:3.

[0017] Preferably, the heterologous expression plasmid in step (2) is selected from either pET-28a(+)-CGTase-13 or pPIC9K-CGTase-13.

[0018] Preferably, the host in step (3) is selected from any one of the following: yeast cells, Pichiapastoris, Saccharomyces cerevisiae, Kluyveromyces lactis, Escherichia coli, Bacillus subtilis, Streptomyces coelicolor, Streptomyces lividans, Streptomyces avermitilis, Streptomyces venezuelae, and Saccharopolyspora erythraea.

[0019] An application of a β-cyclodextrin glucosyltransferase in the preparation of glucosylsteviosides, wherein the β-cyclodextrin glucosyltransferase is used to catalyze the reaction of steviol glycosides and soluble starch to obtain glucosylsteviosides.

[0020] This application provides an application of β-cyclodextrin glucosyltransferase. The applicant uses the β-cyclodextrin glucosyltransferase prepared above as a catalyst to catalyze the production of crude glucosylstevioside from steviol glycosides and soluble starch. After extensive experimentation and optimization, the optimal production conditions were determined. This method has the technical advantages of short production cycle, low cost, high conversion rate, high sweetness of the produced glucosylstevioside, and rapid sweetening speed.

[0021] Preferably, the preparation steps include: using steviol glycosides and soluble starch as substrates, and β-cyclodextrin glucosyltransferase as catalyst to carry out the reaction, and after the reaction is completed, the reaction solution is centrifuged, filtered and dried to obtain crude glucosyl steviol glycosides.

[0022] Preferably, the pH of the reaction is 5.0 to 6.0.

[0023] Preferably, the reaction temperature is 30–50°C.

[0024] Preferably, the reaction time is 16–24 h.

[0025] Compared with the prior art, this application has the following technical effects:

[0026] (1) The β-cyclodextrin glucosyltransferase provided in this application has high steviol glycoside conversion efficiency, with a Stev conversion rate of 86.1% and a RebA conversion rate of 90.8% in steviol glycoside;

[0027] (2) The constructed heterologous expression strain has industrial production value;

[0028] (3) The application of β-cyclodextrin glucosyltransferase provided in this application has the characteristics of short production cycle, low cost and high conversion rate. The glucosylstevioside produced has high sweetness and fast sweetening speed. Attached Figure Description

[0029] Figure 1 This is a plasmid map of plasmid pET-28a(+)-CGTase-13.

[0030] Figure 2 This is a plasmid map of plasmid pPIC9K-CGTase-13.

[0031] Figure 3 SDS-PAGE analysis of β-cyclodextrin glucosyltransferase prepared for expression strains of Escherichia coli.

[0032] Figure 4 SDS-PAGE analysis of β-cyclodextrin glucosyltransferase prepared from Pichia pastoris expression strain.

[0033] Figure 5 HPLC chromatogram to demonstrate the transglycosylation activity of β-cyclodextrin glucosyltransferase expressed in Pichia pastoris.

[0034] Figure 6 Line graphs showing the glycosides under different temperature conditions.

[0035] Figure 7 Line graphs showing the steviosides under different pH conditions.

[0036] Figure 8 Line graphs showing the reaction time of steviol glycosides.

[0037] Figure 9 Line graphs showing the effects of different substrate concentrations and ratios on steviol glycosides. Detailed Implementation

[0038] The present invention will be further described below with reference to embodiments.

[0039] General Implementation Examples

[0040] One or more of the following: a β-cyclodextrin glucosyltransferase, a polypeptide with the amino acid sequence SEQ ID NO:2, a polypeptide and its derivatives having β-cyclodextrin glucosyltransferase activity formed by substituting, deleting or adding one or more amino acid residues of the amino acid sequence SEQ ID NO:2, and a protein fragment containing SEQ ID NO:2 in its amino acid sequence and having β-cyclodextrin glucosyltransferase activity.

[0041] A method for preparing β-cyclodextrin glucosyltransferase, the preparation method is as follows:

[0042] (1) Preparation of polynucleotides: Mass spectrometry analysis of extracellular proteins of Bacillus osmoticus with accession number CGMCC No.23164 was performed, and the potential amino acid sequence of β-cyclodextrin glucosyltransferase SEQ ID NO:2 was found. Polynucleotides were prepared based on the amino acid sequence SEQ ID NO:2.

[0043] (2) Plasmid preparation: The polynucleotides in step (1) are converted into heterologous expression plasmids;

[0044] (3) Preparation of expression strain: The heterologous expression plasmid in step (2) is transformed into the host to prepare a heterologous expression strain;

[0045] (4) Preparation of β-cyclodextrin glucosyltransferase: The heterologous expression strain in step (3) is fermented. After fermentation, the culture is collected and centrifuged. β-cyclodextrin glucosyltransferase is isolated from the fermentation supernatant or bacterial cells obtained by centrifugation.

[0046] An application of a β-cyclodextrin glucosyltransferase in the preparation of glucosylsteviosides, wherein the β-cyclodextrin glucosyltransferase prepared by the above-mentioned method catalyzes the preparation of glucosylsteviosides from starch and steviol glycosides.

[0047] The preparation steps include: using steviol glycosides and soluble starch as substrates, and β-cyclodextrin glucosyltransferase as a catalyst, the reaction is carried out at a pH of 5.0–6.0, a temperature of 30–50℃, and a reaction time of 16–24 h.

[0048] After the reaction is complete, the reaction solution is centrifuged, filtered, and dried to obtain crude glucosylstevioside.

[0049] Example 1: (Preparation of β-cyclodextrin glucosyltransferase by heterologous expression of Escherichia coli)

[0050] A method for preparing β-cyclodextrin glucosyltransferase, the preparation method is as follows:

[0051] (1) Preparation of polynucleotide: Polynucleotide SEQ ID NO:1 was prepared according to the amino acid sequence SEQ ID NO:2;

[0052] (2) Plasmid preparation: such as Figure 1As shown, the heterologous expression plasmid pET-28a(+)-CGTase-13 was prepared by cloning SEQ ID NO:1 in step (1) between the NdeI and XhoI restriction sites of pET28a(+);

[0053] (3) Preparation of expression strain: The plasmid pET-28a(+)-CGTase-13 in step (2) was transformed into Escherichia coli to obtain a heterologous expression strain. BL21 was purified and cultured using the plating method to prepare heterologous expression Escherichia coli. The culture temperature was 37℃ and the culture time was 16h.

[0054] (4) Preparation of β-cyclodextrin glucosyltransferase: Seed culture of heterologous Escherichia coli was prepared by shaking flask culture in 4 ml of liquid LB medium (50 μg / ml kanamycin) at 220 rpm and 30°C for 24 h. The seed culture was then expanded using 400 ml of LB medium at an inoculum size of 1% at 220 rpm and 30°C for 4 h. After expansion, IPTG was added to the fermentation broth for induction culture (final concentration 0.1 mM) at 220 rpm and 16°C for 20 h. After induction culture, the bacterial cells were collected and resuspended in 20 mM liquid LB medium. In PBS (containing 20 mM imidazole), the cells were placed in an ice-water bath and disrupted using a cell disruptor (6 mm diameter amplitude rod, 20% intensity). The sonication frequency was 2 seconds followed by 3 seconds of sonication for 20 minutes. The disrupted mixture was then centrifuged at 22000 rpm for 20 minutes at 4°C. The supernatant was collected. The supernatant was filtered through a 0.22 μm membrane and loaded onto an AKTA system. After loading, the cells were washed with 20 mM PBS (containing 20 mM imidazole) buffer, and UV absorption was observed until the UV absorbance returned to the initial level. The solution was then replaced with 20 mM PBS (containing 100 mM imidazole) buffer, and elution continued until an absorption peak appeared and the UV absorbance returned to the initial level. The solution was then replaced with 20 mM PBS (containing 100 mM imidazole) buffer. Continue elution with PBS (containing 250 mM imidazole) buffer. When the UV absorbance index rises, start collecting the eluent (2 mL / tube) until the UV absorption returns to a level. Replace with 20 mM PBS (containing 500 mM imidazole) buffer and continue elution. When the UV absorbance index rises, start collecting the eluent (2 mL / tube) until the UV absorption returns to a level. Analyze the collected eluent using SDS-PAGE. The results are shown below. Figure 3 As shown.

[0055] Example 2 (Preparation of β-cyclodextrin glucosyltransferase by heterologous expression of Pichia pastoris)

[0056] A method for preparing β-cyclodextrin glucosyltransferase, the preparation method is as follows:

[0057] (1) Preparation of polynucleotides: Polynucleotide SEQ ID NO:3 was prepared according to the amino acid sequence SEQ ID NO:2;

[0058] (2) Plasmid preparation: such as Figure 2 As shown, the heterologous expression plasmid pPIC9K-CGTase-13 was prepared by cloning SEQ ID NO:3 in step (1) between the EcoRI and NotI restriction sites of pPIC9K in pET28a(+);

[0059] (3) Preparation of expression strain: The plasmid pPIC9K-CGTase-13 was digested with SacI enzyme, and the linearized DNA fragment was recovered. Then, it was transformed into Pichia pastoris strain GS115 (Weidi Biotechnology) by chemical transformation to prepare a heterologous expression strain. The heterologous expression strain was plated on MD plates (13.4 g / L yeast basic nitrogen source YNB; 0.4 mg / L biotin; 20 g / L glucose) and cultured at 28℃ for 3 days to obtain transformants. The transformants were screened by YPD-G418 plate, MM / MD plate and PCR to obtain recombinant strain (Mut+ phenotype). This recombinant strain is a heterologous expression Pichia pastoris.

[0060] (4) Preparation of β-cyclodextrin glucosyltransferase: Heterogeneous expression of Pichia pastoris was inoculated into 25 ml of BMGY medium (250 ml shake flask), shaken at 250 rpm at 28-30℃ until OD600 = 2-6, centrifuged at 1500-3000 g for 5 min at room temperature, cells were collected, supernatant was removed, and cells were resuspended in BMMY until OD600 = 1.0 for induction expression (approximately 100-200 ml). The above culture was added to a 1 L shake flask, covered with 4 layers of sterile gauze, and placed in a shaker for continued growth. Methanol was added every 24 h to a final concentration of 1%, and the culture was induced for 96 h. After centrifugation, the extracellular enzyme solution was collected for SDS-PAGE analysis. The analysis results are as follows: Figure 4 As shown.

[0061] Example 3 (Detection of β-cyclodextrin glucosyltransferase activity)

[0062] Using 2% steviol glycosides and 2% soluble starch as substrates, and crude enzyme solution or concentrated enzyme solution (enzyme concentration 20 mg / L) obtained from Pichia pastoris fermentation in Example 2 as catalyst, the reaction was carried out for 22 h in a shaker at 220 rpm, pH 5.0-6.0, and 40 °C. After centrifugation at 12000g for 2 min, the supernatant was collected, diluted 10 times with deionized water, filtered through a 0.22 μm filter membrane, and analyzed by HPLC (the control group had inactivated enzyme solution added after the reaction). Figure 5 The image shows an HPLC chromatogram demonstrating the transglycosylation activity of β-cyclodextrin glucosyltransferase expressed in Pichia pastoris.

[0063] Example 4 (Type determination of β-cyclodextrin glucosyltransferase)

[0064] A 20 g / L soluble starch solution was prepared using 50 mM pH 6.0 Na2HPO4-NaH2PO4 buffer. The enzyme solution obtained in Example 2 was added at a concentration of 20 mg / L. The reaction was carried out at 40 °C and 220 rpm for 18 h. The reaction solution was then inactivated by boiling in a water bath for 10 min. After diluting 10 times, the solution was filtered through a 0.22 μm filter membrane. The contents of α-cyclodextrin, β-cyclodextrin, and γ-cyclodextrin in the reaction solution were determined by HPLC. The results showed that the contents of α-cyclodextrin in the reaction solution were 0.152 ± 0.007 mg / mL, β-cyclodextrin were 0.322 ± 0.024 mg / mL, and γ-cyclodextrin were 0.056 ± 0.005 mg / mL. Therefore, the cyclodextrin glucosyltransferase expressed by Pichia pastoris is of the β-type.

[0065] Example 5 (Optimization of temperature conditions for the conversion of steviol glycosides)

[0066] Stevioside (Zhucheng Haotian Pharmaceutical Co., Ltd., SG90) and soluble starch at a final concentration of 20 g / L were added to the reactor, along with the enzyme solution obtained in Example 2 (added at 20 mg / L). The reaction system consisted of 1 ml of the solution, with a pH of 6-7. The reaction was carried out for 24 h at 20°C, 25°C, 30°C, 40°C, and 50°C, respectively, using a shaker at 220 rpm. The control group was prepared by adding inactivated enzyme solution after the reaction was completed.

[0067] HPLC detection of steviol glycoside conversion: The sample was boiled in water.

[0068] The reaction was terminated by incubation for 5 min, centrifuged at 12000 rpm for 10 min, and the supernatant was diluted 10 times and filtered through a 0.22 μm ultrafiltration membrane for HPLC analysis. The chromatographic conditions were as follows: Agilent 1200 HPLC instrument, Agilent autopilot, Hypersil NH2 column (4.6 mm × 300 mm), DAD detector; the HPLC program is shown in Table 1.

[0069] Table 1 Liquid Phase Program

[0070]

[0071]

[0072] The results are as follows Figure 6 As shown, the optimal temperature for converting steviol glycosides is 40℃.

[0073] Example 6 (Optimization of pH conditions for the conversion of steviol glycosides)

[0074] Stevioside (Zhucheng Haotian Pharmaceutical Co., Ltd., SG90) and soluble starch were added to the reactor at a final concentration of 20 g / L. The concentrated enzyme solution obtained in Example 2 (added amount 20 mg / L) was also added. The reaction system was 1 ml, and the pH values ​​were 4, 5, 6, 7, 8, 9, and 10, respectively. The reaction was carried out in a shaker at 40°C and 220 rpm for 24 h. The control group was treated by adding inactivated enzyme solution after the reaction was completed.

[0075] HPLC detection of steviol glycoside conversion: Same as in Example 5, results are as follows. Figure 7 As shown, the optimal pH for converting steviol glycosides is 6.

[0076] Example 7 (Optimization of reaction time for converting steviol glycosides)

[0077] Stevioside (Zhucheng Haotian Pharmaceutical Co., Ltd., SG90) and soluble starch at a final concentration of 20 g / L were added to the reactor, along with the concentrated enzyme solution obtained in Example 2 (added at 20 mg / L). The reaction system consisted of 1 ml of the solution, and the reaction was carried out in a shaker at 40°C and 220 rpm for 16-24 h. The control group was prepared by adding inactivated enzyme solution after the reaction was completed.

[0078] HPLC detection of steviol glycoside conversion: Same as in Example 5, results are as follows. Figure 8 As shown, the optimal reaction time for converting steviol glycosides is 18 hours.

[0079] Example 8 (Optimization of different substrate concentrations and ratios for the conversion of steviol glycosides)

[0080] Soluble starch solutions of 10, 20, 30, 40 and 50 g / L were prepared using pure water. After dissolution, steviol glycosides (Zhucheng Haotian Pharmaceutical Co., Ltd., SG90) were added to achieve final concentrations of 4, 8, 12, 16 and 20 g / L. The enzyme solution obtained in Example 2 (addition amount 20 mg / L) was added, and the reaction was carried out at 40°C and 220 rpm for 18 h. The reaction solution was then boiled in a water bath for 10 min to inactivate the enzyme.

[0081] HPLC detection of steviol glycoside conversion: Same as in Example 5, results are as follows. Figure 9 As shown, the optimal substrate concentration for enzyme conversion of steviol glycosides is 10 g / L steviol glycosides + 50 g / L soluble starch. The β-cyclodextrin glucosyltransferase obtained in Example 2 achieved conversion rates of 86.1% and 90.8% for the main components of steviol glycosides, Stev and RebA, respectively.

[0082] Example 9 (Sensory Experiment)

[0083] a. Concentration of crude enzyme solution: The enzyme solution obtained in Example 2 was concentrated using a Millipore 15ml / 10kDa ultrafiltration centrifuge tube (concentrated 100 times), and the buffer was exchanged (>1000 times) to remove the culture medium components, so that the enzyme was in ultrapure water to avoid introducing impurities in subsequent reactions.

[0084] b. Glycosylation reaction: Using 2% steviol glycosides (RA97%, Tiancao) and 2% soluble starch (Aladdin) as substrates, and the crude enzyme solution from step a and Toruzyme 3.0L (Novozymes) as catalysts, the reaction was carried out at 40℃ and 220rpm for 22h. After the reaction was completed, the crude steviol glycosides were obtained by centrifugation, filtration and freeze-drying. c. Sensory test: The crude steviol glycosides obtained in step b were finally formulated to a sweetness of 5 degrees sucrose for sensory testing.

[0085] The test results are shown in Table 2. The glucosylstevioside sample catalyzed by β-cyclodextrin glucosyltransferase obtained in Example 2 showed good taste (full-bodied taste), high sweetness, fast sweetening, and almost no off-flavors, and scored high. In contrast, the glucosylstevioside sample catalyzed by Novozymes' Toruzyme 3.0L had more obvious off-flavors and scored lower.

[0086] Table 2 Summary of Sensory Experiment Results

[0087] sample Example 2 Toruzyme 3.0L Sweetness 5.4 5.1 Sweetening speed 5.8 5.4 Aftertaste 3.5 2.9 bitterness 2.0 1.8 astringent 1.9 2.0 Mixed flavors 1.8 1.9 Overall preferences 71.3 68.5

[0088] The above description is merely a preferred embodiment of the present invention and is not intended to limit the present invention in any way. Any simple modifications, alterations, and equivalent transformations made to the above embodiments based on the technical essence of the present invention shall still fall within the protection scope of the present invention.

Claims

1. A method for producing a β-cyclodextrin glucanotransferase, characterized by, The preparation steps include the following: (1) Preparation of polynucleotides: The amino acid sequence SEQ ID NO:2 was codon optimized, and the optimized polynucleotide was SEQ ID NO:3; (2) Preparation of heterologous expression plasmid: The polynucleotide in step (1) is converted into a heterologous expression plasmid, which is pPIC9K-CGTase-13; (3) Preparation of heterologous expression strain: Transform the heterologous expression plasmid in step (2) into the host to prepare a heterologous expression strain; (4) Preparation of β-cyclodextrin glucosyltransferase: The heterologous expression strain in step (3) is fermented. After fermentation, the culture is collected and centrifuged. β-cyclodextrin glucosyltransferase is isolated from the fermentation supernatant or bacterial cells obtained by centrifugation.

2. The production method according to claim 1, wherein The host in step (3) is Pichia pastoris.

3. The application of a β-cyclodextrin glucosyltransferase prepared according to any one of claims 1-2 in the preparation of glucosylsteviosides, characterized in that, Glucosylstevioside was prepared by catalyzing steviol glycosides and soluble starch using the aforementioned β-cyclodextrin glucosyltransferase.

4. The application according to claim 3, characterized in that, The preparation steps include: using steviol glycosides and soluble starch as substrates, and β-cyclodextrin glucosyltransferase as catalyst for reaction; after the reaction is completed, the reaction solution is centrifuged, filtered and dried to obtain crude glucosyl steviol glycosides.

5. The application according to claim 3, characterized in that, The pH of the reaction is 5.0~6.

0.

6. The application according to claim 5, characterized in that, The pH is 6.

0.

7. The application according to claim 3, characterized in that, The reaction temperature is 30~50℃.

8. The application according to claim 3, characterized in that, The reaction time is 16-24 hours.

Citation Information

Patent Citations

  • Method of industrial quick production and preparation of glucosyl stevioside mixture

    CN108103127A

  • Preparation method of glucosyl stevioside

    CN111662941A

  • Large-island saline-alkali bacillus capable of producing cyclodextrin glucosyltransferase and application of large-island saline-alkali bacillus

    CN114369543A